about
Observational Study: Familial Relevance and Oncological Significance of Revised Bethesda Guidelines in Colorectal Patients That Have Undergone Curative ResectionComparison of abdominal and perineal procedures for complete rectal prolapse: an analysis of 104 patients.Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer.Post-pulmonary metastasectomy prognosis after curative resection for colorectal cancerImpression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer.Multiple Glomus Tumors of the Omentum.Neoadjuvant treatment response as an early response indicator for patients with rectal cancerReverse-hybrid robotic mesorectal excision for rectal cancerPretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiationComparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.Surgical Treatment of Crohn Colitis Involving More Than 2 Colonic Segments: Long-Term Outcomes From a Single InstitutionOncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.Variability in the lymph node retrieval after resection of colon cancer: Influence of operative period and process.Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer.Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapyFactors affecting poor nutritional status after small bowel resection in patients with Crohn disease.The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancerClinicopathological features and surgical options for synchronous colorectal cancer.Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?Matched case-control analysis comparing oncologic outcomes between preoperative and postoperative chemoradiotherapy for rectal cancer.Individualized treatment for a rectourethral fistula: rare complications.Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin.Factors affecting the postoperative morbidity and survival of patients with liver cirrhosis following colorectal cancer surgery.Down-regulated expression of ATG5 in colorectal cancer.Palliative surgery for colorectal cancer with peritoneal metastasis: a propensity-score matching analysis.Comparative analysis focusing on surgical and early oncological outcomes of open, laparoscopy-assisted, and robot-assisted approaches in rectal cancer patients.The types of anastomotic leakage that develop following anterior resection for rectal cancer demonstrate distinct characteristics and oncologic outcomes.Effect of a purse-string approximation following stoma takedown on wound infection and satisfaction.The prognostic significance and treatment modality for elevated pre- and postoperative serum CEA in colorectal cancer patientsPostoperative changes of manometry after restorative proctocolectomy in Korean ulcerative colitis patients.Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer.Importance of prompt diagnosis in the management of colonoscopic perforation.A giant colonic hamartoma and multiple colonic hamartomatous polyps in a middle-aged man.Efforts to Find Targets Involving Angiogenesis: Step to Improve the Efficacy of Target Therapy in the Era of Colorectal Cancer Treatment.Impairment of Immunonutritional Status During Treatment is a Factor Associated With Oncologic Outcomes in Patients With Rectal Cancer Treated With Preoperative Chemoradiotherapy.Extranodal extension status is a powerful prognostic factor in stage III colorectal cancer.Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis.Different patterns of lymphatic spread of sigmoid, rectosigmoid, and rectal cancers.
P50
Q27315851-BF680AEC-C184-49E4-8E81-C4F703ACAD0FQ33627458-7EDA6475-D89B-49B8-875A-432DB26DA305Q33746839-767326C8-7C3D-4D3A-B050-D368AB6E583AQ33829566-C076BD70-7FEC-4E67-9B81-DC8A16B3FACEQ34932625-089EA6CA-77A8-4E11-941B-E5EEBCF1792FQ36043781-1B787FD9-CD2A-4EAE-903D-C8E49D9B261AQ36058487-14278CE0-477C-4756-AF0B-D0F9EB8C9833Q36537946-6DA2BB6A-7FD1-4D4E-B918-A37B868751F1Q36537952-600A84F6-5DD7-4017-BD54-637E2D1950CDQ36540452-72785CB0-DA6A-417B-AAC1-A74439B4FC14Q36988761-29850B35-C8E0-49FB-8B33-321A7CD8B624Q36993173-82B5F524-D300-4B5D-B4C7-1E4A427115ACQ37164916-BEEEF903-94C5-4F7A-B8FD-B516243D73C6Q37328335-CB2ECAF6-FB23-44E2-9989-E8337A3EE105Q37433728-EF42BDDC-8AC6-48FA-8334-1584D4C6A258Q37602735-A5F5279B-DCDD-4567-A887-86EEAC281DA7Q37605626-686983BF-8445-47E0-A4D1-32F224F93E79Q37605916-82A81F99-A82D-44EE-9B9B-979D2C08CF62Q37684911-8F003424-0DC0-45C7-8121-41A45DE4F8BCQ37705840-57C70306-5DB4-4ADC-ADB8-E805E6AD0448Q37735934-35C01D8C-1D96-4BD6-A3A3-614E24C6F153Q38267794-0E5229E9-015E-45A5-8085-8985B6112FD7Q38496466-CDF3A914-DC36-4E49-A2D6-15EF6AAE7882Q39093316-B4E8E47D-7DF7-4362-9F38-F71ED284879DQ39275294-E2918553-B54F-432D-8BDE-3D58D67A7DD5Q39465411-70BE46B4-4AB5-47D3-B78B-0A2B65478316Q40713772-1C56011F-F430-4CD2-BFD7-6670C7EFAC31Q41060252-76A6228A-D09A-469B-80A1-D3AA8F2A9F7BQ41446507-0DB81E53-4780-436F-9C0F-02D922A2DE84Q41461399-21F52E8B-3202-4742-AA8E-25A6DE9CA036Q41505629-EDDD445C-2206-4801-8C1E-F92C6551C84BQ41675829-2C61A89B-2698-4CF9-A310-2D3209A66848Q41709703-66809644-0930-49CC-99C6-7D07B71F3684Q42086877-33852621-5C9D-4D26-981A-5630E65FB744Q42122786-695A90BC-6AE8-4092-AF71-9DED42FF3A36Q42316986-E6C16763-DD38-47AC-BB15-11A4ABD9AB8CQ42328605-15E548F8-3576-4EC7-9837-25C68D9C2106Q42365274-FB1E39E6-390A-4B4E-8656-E50E2F9D0285Q43379571-73A8B70B-BB3A-498D-9CD9-96436288E46BQ43874998-B5FF095C-C78A-4662-8802-318FFD9C69AE
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
In Ja Park
@en
In Ja Park
@nl
type
label
In Ja Park
@en
In Ja Park
@nl
prefLabel
In Ja Park
@en
In Ja Park
@nl
P106
P31
P496
0000-0001-5355-3969